Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

“This study confirms that combined cholesterol lowering therapy should be considered immediately and should be the gold ...

A recent study made a shocking and life saving finding that combining statins with ezetimibe lowers LDL-C levels ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

High cholesterol causes plaque buildup in arteries, which can restrict blood flow and lead to heart attack or stroke. Statins, which reduce cholesterol levels, are commonly prescribed to people at ...

Discover how statin use in chronic liver disease lowers liver cancer and decompensation risks, with added benefits from ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found.  New ...